Adelberg Amy M, Kuller Jeffrey A
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, 214 MacNider, Chapel Hill, NC 27599-7516, USA.
Obstet Gynecol Surv. 2002 Oct;57(10):703-9. doi: 10.1097/00006254-200210000-00024.
Inherited and acquired thrombophilias have been associated with recurrent pregnancy loss. Over recent years our ability to detect protein and genetic abnormalities responsible for thrombotic tendency has improved. We are now left with the task of deciphering which of these thrombophilias carries an increased risk for recurrent pregnancy loss. Acquired thrombophilias including lupus anticoagulant and anticardiolipin antibodies have been linked to recurrent pregnancy loss. However the evidence for the role of inherited thrombophilias such as, heterozygosity for the factor V Leiden, prothrombin G20210A mutation, the methylenetetrahydrofolate reductase (C677T MTHFR) mutation, as well as deficiencies of antithrombin, protein C and protein S is less clear. The methods for diagnosis and the evidence for their associations are discussed in this paper. Treatment modalities independent of those needed to prevent thrombotic events in pregnancy have generally not been studied. Given the present available data, there is insufficient evidence to include inherited thrombophilias in the initial evaluation of RPL. It is important to look for other, more common, causes of recurrent miscarriage in the evaluation of these patients.
遗传性和获得性易栓症与复发性流产有关。近年来,我们检测导致血栓形成倾向的蛋白质和基因异常的能力有所提高。现在我们面临的任务是解读这些易栓症中哪些会增加复发性流产的风险。包括狼疮抗凝物和抗心磷脂抗体在内的获得性易栓症已与复发性流产相关联。然而,诸如因子V Leiden杂合子、凝血酶原G20210A突变、亚甲基四氢叶酸还原酶(C677T MTHFR)突变以及抗凝血酶、蛋白C和蛋白S缺乏等遗传性易栓症的作用证据尚不明确。本文讨论了这些易栓症的诊断方法及其相关性证据。通常尚未研究独立于预防孕期血栓形成事件所需的治疗方式。根据目前可得的数据,没有足够的证据将遗传性易栓症纳入复发性流产的初始评估中。在评估这些患者时,寻找复发性流产的其他更常见原因很重要。